NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 140 filers reported holding NEKTAR THERAPEUTICS in Q1 2014. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $449,000 | +28.7% | 28,952 | 0.0% | 0.09% | +36.4% |
| Q3 2014 | $349,000 | -5.9% | 28,952 | 0.0% | 0.07% | -5.7% |
| Q2 2014 | $371,000 | +5.7% | 28,952 | 0.0% | 0.07% | +7.7% |
| Q1 2014 | $351,000 | +6.7% | 28,952 | 0.0% | 0.06% | +10.2% |
| Q4 2013 | $329,000 | +8.9% | 28,952 | 0.0% | 0.06% | +11.3% |
| Q3 2013 | $302,000 | -9.6% | 28,952 | 0.0% | 0.05% | -24.3% |
| Q2 2013 | $334,000 | – | 28,952 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 598,400 | $10,083,000 | 3.98% |
| Opus Point Partners Management, LLC | 348,583 | $5,874,000 | 3.88% |
| Camber Capital Management LP | 3,500,000 | $58,975,000 | 3.81% |
| 1492 Capital Management LLC | 180,601 | $3,043,000 | 2.21% |
| Virtus ETF Advisers LLC | 38,260 | $645,000 | 1.77% |
| Cormorant Asset Management, LP | 765,156 | $12,893,000 | 1.54% |
| Rhenman & Partners Asset Management AB | 581,000 | $9,790,000 | 1.48% |
| Granahan Investment Management | 2,082,155 | $35,084,000 | 1.21% |
| BRIDGER MANAGEMENT, LLC | 1,563,862 | $26,351,000 | 0.87% |
| RICE HALL JAMES & ASSOCIATES, LLC | 899,531 | $15,157,000 | 0.87% |